These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2108094)

  • 41. Fluorescent labeling of signal-transducing G-proteins. Pertussis toxin-catalyzed etheno-ADP ribosylation of transducin.
    Hingorani VN; Ho YK
    J Biol Chem; 1988 Dec; 263(36):19804-8. PubMed ID: 3143731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and immunological properties of the five subunits of pertussis toxin.
    Nicosia A; Bartoloni A; Perugini M; Rappuoli R
    Infect Immun; 1987 Apr; 55(4):963-7. PubMed ID: 3549567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient production of active and mutated ADP-ribosyltransferase (S1) of pertussis toxin using affinity expression cassette polymerase chain reaction.
    Raupach B; Marzillier J; Schmidt MA
    FEMS Immunol Med Microbiol; 1994 Mar; 8(3):197-206. PubMed ID: 8004055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin.
    Kaslow HR; Schlotterbeck JD; Kenimer JG
    Infect Immun; 1990 Mar; 58(3):746-52. PubMed ID: 2155182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pertussis toxin and target eukaryotic cells: binding, entry, and activation.
    Kaslow HR; Burns DL
    FASEB J; 1992 Jun; 6(9):2684-90. PubMed ID: 1612292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
    Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
    J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition by pertussis toxin of guanyl nucleotides exchange on transducin in bovine rod cell membranes.
    Rybin VO; Gureeva AA; Tkachuk VA
    Membr Biochem; 1989; 8(2):115-26. PubMed ID: 2561302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.
    Locht C; Cieplak W; Marchitto KS; Sato H; Keith JM
    Infect Immun; 1987 Nov; 55(11):2546-53. PubMed ID: 3117686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in the S1 subunit of pertussis toxin that affect secretion.
    Craig-Mylius KA; Stenson TH; Weiss AA
    Infect Immun; 2000 Mar; 68(3):1276-81. PubMed ID: 10678938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli.
    Smith AM; Yan H; Groves N; Dalla Pozza T; Walker MJ
    FEMS Microbiol Lett; 2000 Oct; 191(2):177-82. PubMed ID: 11024260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleotide exchange and cGMP phosphodiesterase activation by pertussis toxin inactivated transducin.
    Ramdas L; Disher RM; Wensel TG
    Biochemistry; 1991 Dec; 30(50):11637-45. PubMed ID: 1661143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.
    Antoine R; Locht C
    Infect Immun; 1990 Jun; 58(6):1518-26. PubMed ID: 2341166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins.
    Kenimer JG; Probst PG; Karpas AB; Burns DL; Kaslow HR
    Dev Biol Stand; 1991; 73():133-41. PubMed ID: 1778307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary X-ray crystallographic analysis of holotoxin from Bordetella pertussis.
    Raghavan M; Gotto JW; Scott JV; Schutt CE
    J Mol Biol; 1990 Jun; 213(3):411-4. PubMed ID: 2352276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
    Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
    Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin.
    Barbieri JT; Cortina G
    Infect Immun; 1988 Aug; 56(8):1934-41. PubMed ID: 3135265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subunit structure and enzymic activity of pertussis toxin.
    Burns DL
    Microbiol Sci; 1988 Sep; 5(9):285-7. PubMed ID: 2908558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.
    Sekura RD; Fish F; Manclark CR; Meade B; Zhang YL
    J Biol Chem; 1983 Dec; 258(23):14647-51. PubMed ID: 6315733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Purification and properties of Bordetella pertussis toxin].
    Gureeva AA; Grigorian GIu; Rybin VO; Pereverzev NA; Lapaeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):32-7. PubMed ID: 3529763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.